MedTrace Logo

Liver Transplantation in Alcoholic Hepatitis

NCT01768715 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-06-03

No results posted yet for this study

Summary

Patients with alcoholic hepatitis non-responsive to steroids have a poor prognosis. Recently a French-Belgian prospective study has obtained good results (acceptable survival with a low rate of alcohol recidivism).

The hypothesis of the present study is that carefully selected Spanish patients with alcoholic hepatitis that do not respond to steroid therapy may have a good survival if they receive a liver transplant. The expected rate of alcohol recidivism in such a selected population will be low.

Conditions

  • Alcoholic Hepatitis

Sponsors & Collaborators

  • Fundación Mutua Madrileña

    collaborator OTHER

  • Sociedad Española de Trasplante Hepático

    lead NETWORK

Principal Investigators

  • Ignacio Herrero, MD · Clinica Universidad de Navarra

  • Santiago Tome, MD · Complejo Hospitalario Universitario de Santiago

  • Ignacio Gonzalez-Pinto, MD · Hospital Central de Asturias

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-12-31
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768715 on ClinicalTrials.gov